Zhouxiang Chen
About Zhouxiang Chen
Zhouxiang Chen is a Scientist at Bristol Myers Squibb in Cambridge, Massachusetts, specializing in Immuno-Oncology Biomarkers and multi-color flow cytometry.
Title
Zhouxiang Chen is a Scientist currently working at Bristol Myers Squibb in Cambridge, Massachusetts, United States.
Current Role at Bristol Myers Squibb
Since January 2022, Zhouxiang Chen has been employed at Bristol Myers Squibb in the capacity of a Scientist. In his role, he supports the Immuno-Oncology Biomarker group by developing whole blood assays such as Phosflow and Target occupancy assays. Chen also evaluates and validates different pharmacodynamic (PD) biomarkers across multiple projects.
Previous Experience at EMD Serono and Sanofi
Zhouxiang Chen worked at EMD Serono, Inc. in Billerica, Massachusetts, as a Scientist from 2017 to 2022. He initially joined the company as a Research Associate Co-op in 2016 for five months in the Greater Boston Area. Prior to that, he interned at Sanofi in Hangzhou, Zhejiang, China, as a QC intern for three months in 2015.
Educational Background
Zhouxiang Chen possesses a Master of Science (M.S.) degree in Biotechnology from Northeastern University, which he achieved after studying from 2014 to 2016. Prior to that, he earned a Bachelor of Science (BS) degree in Biochemistry from the Florida Institute of Technology, studying between 2012 and 2014. He also studied at Zhejiang Gongshang University.
Technical Expertise
Zhouxiang Chen has expertise in developing whole blood assays, evaluating pharmacodynamic biomarkers, and building Immuno-profiling platforms for blood and tumor samples using multi-color flow cytometry. He possesses skills in various in-vitro assays, including PCR and cell culture.